| 論文種別 | 原著(症例報告除く) |
| 言語種別 | 英語 |
| 査読の有無 | その他(不明) |
| 表題 | Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma |
| 掲載誌名 | 正式名：Clinical genitourinary cancer 略 称：Clin Genitourin Cancer ISSNコード：15587673 |
| 掲載区分 | 国外 |
| 巻・号・頁 | pp.Online ahead of print |
| 著者・共著者 | Takahashi M, Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K,
Numakura K, Yamana K, Kandori S, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Yamashita S, Taniguchi H, Monji K, Ishiyama R, Kawasaki Y, Kato T, Tatarano S, Masui K, Nakamura E, Kaneko T, Miyake M, Kitano G, Motoshima T, Shiraishi Y, Kira S, Murashima T, Hara H, Matsumura M, Kitamura H, Miyake H, Furukawa J; Japanese Urological Oncology Group. |
| 発行年月 | 2025/02 |
| DOI | 10.1016/j.clgc.2025.102322 |
| PMID | 40118720 |